Abstract
Aminoxyl radicals have been suggested as potential MRI contrast agents for the last 10 years (1) but no clinically accepted examples for human applications have been approved to date. The following questions appear to need evaluation: (a) advantages of aminoxyl radicals as contrast agents in comparison to other chemical agents currently available; (b) toxicity and ways to ameliorate this property; (c) factors which influence biological lifetimes with suggested improvements; (d) versatility through derivatization; (e) pharmacologic properties as compared to other chemical contrast agents.
This is paper #010 supported from the University of Guelph MRI Facility budget
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Koenig SH, Brown RD (1984) Relaxation of solvent protons by paramagnetic ions and its dependence on magnetic field and chemical environment. Implications for NMR imaging. Magn Reson Med 1: 478
Brasch RC (1983) Methods of contrast enhancement for NMR imaging and potential applications. Radiology 147: 781
Runge VM, Clanton JA, Lukehart CM, Partain CI, James AF Jr (1983) Paramagnetic agents for contrast enhanced NMR imaging: A review. Amer J Roentgen 141: 1209
Bydder GM (1988) In: Stark DD, Bradley WG Jr (eds) Clinical application of gadoliniumDTPA in magnetic resonance imaging. Magnetic Resonance Imaging Mosby, Toronto, Chap 10, pp 182
Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadoliniumDTPA complex: a potential NMR contrast agent. Amer J Roentgen 142: 619
Aminoxyl is the name recommended by the International Union of Pure and Applied Chemistry; nitroxyl and nitroxide is also in current use
Forrester AR, Hay JM, Thompson RH (1968) Nitroxides. In: Organic chemistry of stable free radicals. Academic Press, New York, pp 189
Brasch RC, McNamara MT, Ehman RL, Couet WR, Tozer TN, Sosnovsky G, Rao NVM, Prakash I (1989) Influence of chemical structure on nitroxyl spin label magnetic relaxation characteristics. Eur J Med Chem 24: 335
Hall DL, Hogan PG (1988) NMR measurement of the degree of oil/water partition of paramagnetic contrast media. Mag Res Med 7: 248
Sosnovsky G, Rao NKVM, Lukszo J, Brasch RC (1986) Spin labelled bovine serum albumin, spin labelled bovine serum albumin chelating agents and their gadolinium complexes. Potential contrast enhancing agents for magnetic resonance imaging. Z Naturforsch 416: 1170
Slane JMK, Lai GS, Hyde JS (1986) A proton relaxation enhancement investigation of the binding of fatty acid spin labels to human serum albumin. Mag Res Med 3: 699
Daszkiewicz.OK, Hennel JW, Lubas B, Szczepkowski TW (1963) Proton magnetic relaxation and protein hydration. Nature 200: 1006
Sosnovsky G, Li SW, Rao VM (1985) Spin labelled chelating agents and their gadolinium complexes as contrast enhancing agents for NMR imaging. Z Naturforsch 40b: 1558
Ehman RI, Brasch RC, McNamara MT, Erikkson V, Sosnovsky G, Lukszo J, Li SW (1986) Diradical nitroxyl spin label contrast agents for magnetic resonance imaging. A comparison of relaxation effectiveness. Investigative Radiology 21: 125
Polnaszek CF, Bryant RG (1985) The magnetic field dependence of transverse water proton relaxation induced by nitroxide radicals. Mag Res Med 2:296 and references therein
Lovin JD, Wesbey GE, Engelstad BL, Sosnovsky G, Moseley M, Tuck DI, Brasch RC (1985) Magnetic field dependence of spin–lattice relaxation enhancement using piperidinyl nitroxyl spin labels. Mag Res Imaging 3: 73
Bennett HF, Brown III RD, Koenig SH, Swartz HM (1987) Effects of nitroxides on the magnetic field and temperature dependence of 1/T, of solvent water protons. Mag Res Med 4: 93
Mendonca-Dias MH, Gaggelli F, Lauterbur PC (1983) Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Seminars in Nuclear Medicine 13, #4 (Oct), 364
Brasch RC (1983) Work in Progress: Methods of contrast enhancement for NMR imaging and potential applications. Radiology 147: 781
Brasch RC, London DA, Wesbey GE, Tozer RN, Nitecki DE, Williams RD, Doemeny J, Tuck LD, Lallemand DP (1983) Work in Progress. Nuclear magnetic resonance with a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 147: 773
Brasch RC, Nitecki DE, Brant-Zawadski M, Enzmann DR, Wesbey GE, Tozer TN, Tuck LD, Cann CE, Fike JR, Sheldon P (1983) Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: Preliminary Report. Amer I Roentgen 141: 1019
Ehman RL, Wesbey GE, Moon KL, Williams RD, McNamara MT, Couet WR, Tozer TN, Brasch RC (1985) Enhanced MRI of tumors utilizing a new nitroxyl spin label contrast agent. Mag Res Imaging 3: 89
McNamara MT, Wesbey GE, Brasch RC, Sievers R, Lipton MJ, Higgins CB (1985) Magnetic Resonance Imaging of acute myocardial infarction using a nitroxyl spin label ( PCA ). Invest Radio] 20: 591
Lamarque JL, Almes C, Rouanet JP, Prat X, Bruel JM, Pujol J, Rodiere MJ, Martin JM, Lopez P, Rossi M, Zanca M, Bonet PA, Subra G, Sune A, Robbe Y, Boucard M, Michel A, Fenandez JP, Chapat JP (1986) Ideal Imaging in MR: contrast-enhancing pharmaceuticals, in this investigation 4-carboxy-2,2,6,6-tetramethylpiperindine-N-oxyl was used. Europ J Radiol 6: 48
Rosen GM, Griffeth LK, Brown MA, Drayer BP (1987) Intrathecal administration of nitroxides as potential contrast agents for MR imaging. Radiology 163: 239
Grodd W, Paajanen H, Eriksson UG, Resel D, Terrier F, Brasch RC (1987) Comparison of ionic and non-ionic nitroxide spin labels for urographic enhancement in magnetic resonance imaging. Acta Radiologica 28: 593
Oehler U, Janzen EG, Betteridge K, Fyfe C, Towner R, Savage N, Scodras J (1990) Investigation of the horse conceptus via magnetic resonance imaging ( MRI) and nitroxide spin labels as contrast agents. Free Radicals Research Communications 9: 391
Eriksson UG, Schuhmann G, Brasch RC, Tozer TN (1988) Pharmacokinetics in the rat and the dog of a nonionic nitroxide contrast agent for magnetic resonance imaging. Pharmaceutical Sciences 77: 97
Afzal V, Brasch RC, Nitecki DE, Wolff S (1984) Nitroxyl spin label contrast enhancers for magnetic resonance imaging: Studies of acute toxicity and mutagenesis. Invest Rad 19: 549
Gordon DG, Brasch RC, Ogan MD, Deen D (1988) Pyrroxamide, a nonionic nitroxyl spin label contrast agent for magnetic resonance imaging: Mutagenesis and cell survival. Invest Rad 23: 616
Griffith IK, Rosen GM, Rauckman EI, Drayer BP (1984) Pharmacokinetics of nitroxide NMR contrast agents. Invest Radiol 19: 553
Emanuel NM, Konovalova NP, Dyachkovskaya RP (1976) Toxicity, antitumor activity and pharmacokinetics of spin-labeled thio-TEPA analogs. Cancer Treatment Reports 60: 1605
Zhdanov RI, Kadenatsi IB, Mashkovsky YS, Lavretskaya EP, Piruzyan LA (1979) Biologically active stable radicals, XIII. Pharmacological activity and distribution in vivo of nitroxyl paramagnetic models of some phsychotropic compounds. Life Sciences 25: 2163
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin, Heidelberg
About this chapter
Cite this chapter
Janzen, E.G., Towner, R.A. (1992). Aminoxyl Radicals as MRI Contrast Agents. In: Zhdanov, R.I. (eds) Bioactive Spin Labels. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48724-8_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-48724-8_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-48726-2
Online ISBN: 978-3-642-48724-8
eBook Packages: Springer Book Archive